共 1 条
Alternate end-game strategies towards Nirmatrelvir synthesis: Defining a continuous flow process for the preparation of an anti-COVID drug
被引:2
|作者:
Veeramani, Karuna
[1
]
Shinde, Manish
[1
]
Eda, Vishnuvardhana Vema Reddy
[2
]
Darapaneni, Bala Chennaiah
[2
]
Hindupur, Rama Mohan
[3
]
Madarapu, Srinivasa Rao
[3
]
Sen, Saikat
[2
]
Oruganti, Srinivas
[2
]
机构:
[1] Univ Hyderabad Campus, Dr Reddys Inst Life Sci, Chem Proc Automation Lab 10X, Hyderabad 500046, Telangana, India
[2] Univ Hyderabad Campus, Dr Reddys Inst Life Sci, Ctr Proc Res & Innovat, Hyderabad 500046, Telangana, India
[3] Aurigene Pharmaceut Serv Ltd, JP Nagar Rd, Hyderabad 500049, Telangana, India
关键词:
Nirmatrelvir;
Continuous flow synthesis;
Mixed anhydride;
Amidation;
Nitrile formation;
1-Propanephosphonic acid anhydride (T3P);
INGREDIENT;
D O I:
10.1016/j.tetlet.2023.154344
中图分类号:
O62 [有机化学];
学科分类号:
070303 ;
081704 ;
摘要:
Scalable alternate end-game strategies for the synthesis of the anti-COVID drug molecule Nirmatrelvir (1, PF-07321332) have been described. The first involves a direct synthesis of 1 via amidation of the carboxylic acid 7 (suitably activated as a mixed anhydride with either pivaloyl chloride or T3P) with the amino-nitrile 10 center dot HCl. T3P was found to be a more practical choice since the reagent promoted efficient and concomitant dehydration of the amide impurity 9 (derived from the amino-amide contaminant 8 center dot HCl invariably present in 10 center dot HCl) to 1. This observation allowed for the development of the second strategy, namely a continuous flow synthesis of 1 from 9 mediated by T3P. Under optimized conditions, this conversion could be achieved within 30 min in flow as opposed to 12-16 h in a traditional batch process. The final API had quality attributes comparable to those obtained in conventional flask processes.(c) 2023 Elsevier Ltd. All rights reserved.
引用
收藏
页数:5
相关论文